choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Receptos IPO

Receptos IPO Newsletter
  • Value Creation And Destruction: Dispersion Of Performance In Biotech IPOs 17 Apr 2020 13:51 GMT

    … “very constructive” for getting IPOs priced today. We should … LifeSciVC Of note, the IPO classes that predominantly priced during … and launching CART products, or Receptos’ ozanimod FDA hurdles, or … IPOs had never “broken issue” by falling below their IPO …

  • From Launch To IPO In 13 Months: Gossamer Bio CEO Says She’s Running Company Of Her Dreams 11 Feb 2019 21:31 GMT

    … of Gossamer BioWhen Celgene bought Receptos in 2015, Dr. Sheila … Polaris Partners and had its initial public offering raising another $276 million through … to asthma. Planning an IPO in just over a year … a rarely used fixed price IPO that would allow the …

  • Gossamer Bio Adds $276M in Second Biotech “Unicorn” IPO of 2019 08 Feb 2019 03:57 GMT

    … former Receptos executives, has raised $276 million in its initial public offering, a … symbol “GOSS.” The Gossamer IPO comes just over one week … . Last year, according to IPO research firm Renaissance Capital, only … it will use the IPO cash to advance its …

  • Gossamer Bio Back to a Traditional IPO Path 31 Jan 2019 19:53 GMT

    … government shutdown freezing the initial public offering market. With the government … workaround, in which its IPO registration statement would have … team led by ex-Receptos executives, Gossamer has been … a yearlong moratorium on IPOs. “They had to wait …

  • Gossamer Bio Files for IPO at End of Year in Which it Raised $330M 24 Dec 2018 21:19 GMT

    … Bio, headed by former Receptos executives, made its public … outlined plans for an initial public offering to advance its development … plans to use the IPO proceeds to fund research … drugs. Sheila Gujrathi, previously Receptos’s chief medical officer, …

  • Alector kicks off next wave of biotech IPOs 08 Feb 2019 13:04 GMT

    … 35 days had deterred new IPOs in biotech, but market launches … no licensed treatments. A third IPO expected this week is from … Gujrathi, two former execs from Receptos - the company bought out …

  • U.S. IPO Week Ahead: 2 Billion-Dollar Biotechs In A 4-IPO Week 02 Feb 2019 23:55 GMT

    … experienced management team previously sold Receptos for $7.2 billion … 51 million. IPO Market Snapshot The Renaissance IPO Indices are … Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, … 's International IPO ETF (NYSE: IPOS) tracks the index, …

  • With SEC Reopened, Gossamer Bio Turns Back from Alternative IPO Path 31 Jan 2019 21:47 GMT

    … return to a conventional IPO that is reviewed by … its offering under the alternative IPO path, proposing to sell … biotech was founded by former Receptos executives in 2015 following … co-founder Sheila Gujrathi, formerly Receptos’s chief medical officer, was …

  • Celgene buys Receptos for $7.3 billion 15 Jul 2015 02:10 GMT

    … -dollar company since its initial public offering in 2013. Receptos shares have surged more … this inflammation and immunology franchise.” Receptos has 68 employees, according to … and psoriatic arthritis treatment Otezla. Receptos doesn’t have any approved …

Satisfied with the content?

Continue to create your account.